George Alyateem

Also affiliated with Center for Cancer Research

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The Evolving AML Genomic Landscape: Therapeutic Implications”.

The Evolving AML Genomic Landscape: Therapeutic Implications

Current Cancer Drug Targets(2020)10.2174/1568009620666200424150321

N/A

0DataRank · unranked

9 citations

George Alyateem, Christin B. DeStefano, Michael M. Gottesman, Sachi Horibata

Current Status and Future Targeted Therapy in Adrenocortical Cancer

Frontiers in Endocrinology(2021)10.3389/fendo.2021.613248

N/A

0DataRank · unranked

42 citations

Naris Nilubol, George Alyateem

Use of CRISPR-based screens to identify mechanisms of chemotherapy resistance

Cancer Gene Therapy(2023)10.1038/s41417-023-00608-z

N/A

0DataRank · unranked

17 citations

Heidi M. Wade, Aaron A. Bickert, Crystal C. Lipsey, Priya Mondal, MacKinzie D. Smith +5 more

A whole-genome CRISPR screen identifies the spindle accessory checkpoint as a locus of nab-paclitaxel resistance in a pancreatic cancer cell line

Scientific Reports(2024)10.1038/s41598-024-66244-1

N/A

0DataRank · unranked

6 citations

George Alyateem, Allison V. Mitchell, Michael M. Gottesman, Priya Mondal